Related Experiment Video
Updated: Mar 3, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Effect of a Pediatric Prescription Medication Discharge Program on Reducing Hospital Readmission Rates
Insights
This study found that a pediatric prescription medication discharge program did not reduce hospital readmissions. The program
Area of Science:
- Pediatric Healthcare
- Hospital Readmission Research
- Medication Management
Background:
- Pediatric prescription medication discharge programs aim to improve patient outcomes.
- Evaluating the effectiveness of such programs is crucial for optimizing healthcare delivery.
- Hospital readmissions in pediatric populations represent a significant concern for healthcare systems.
Purpose of the Study:
- To assess the impact of a pediatric prescription medication discharge delivery and counseling program.
- To determine if the program effectively reduces 30-day hospital readmissions in pediatric patients.
- To identify factors associated with readmission and program participation.
Main Methods:
- Retrospective chart review of electronic medical records for patients under 21 years old.
- Comparison of patients who participated in the discharge program versus non-participants.
- Analysis of 30-day readmission rates, time to readmission, and diagnoses at discharge.
Main Results:
- Out of 932 analyzed patients, 393 participated in the program.
- The readmission rate was 13.2% for participants and 12.4% for non-participants (p = 0.717).
- Diagnoses of malignancy and kidney injury were linked to higher readmission rates; heart defects and malignancy were linked to higher program participation.
Conclusions:
- Participation in the pediatric discharge medication program did not significantly decrease 30-day hospital readmission rates.
- The program's effectiveness in reducing readmissions requires further investigation.
- Specific diagnoses may influence both readmission risk and program engagement.
Objectives:
To evaluate the pediatric prescription medication discharge delivery and counseling program, implemented at an 186-bed children's hospital integrated within a larger academic medical center, and its effectiveness on reducing hospital readmissions.
Methods:
This study was a retrospective chart review of existing data in the electronic medical record from patients <21 years of age who were discharged from our institution between September 1, 2014, and November 30, 2014. Patients who participated in the pediatric discharge program were compared to non-participants. The primary objective was to determine if the patient was readmitted within 30 days. Secondary objectives included time until readmission, diagnosis at discharge, and hospital unit at discharge.
Results:
In total, 1804 patients were assessed. After exclusions, 932 subjects were included in the analysis. In total, 393 (42.2%) patients participated in the pediatric medication discharge and counseling program, and 539 did not participate. Of the patients who participated in the program, 52 were readmitted within 30 days (13.2%), compared with 67 patients (12.4%) who did not participate in the discharge program, p = 0.717. Patients with the diagnoses of malignancy and kidney injury were more likely to be readmitted within this time frame, and those with the diagnoses of heart defects or cardiology disorders and malignancy were more likely to participate in the pediatric prescription medication discharge program.
Conclusion:
Participation in the pediatric discharge medication delivery and counseling program did not reduce hospital readmission rate within 30 days.
More Related Videos
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Discharge Summary Forms
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug Dosing: Infants and Children
Pharmaceutical Poisoning: Potential Scenarios
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

